Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 29 MAY 2020

The Battle For Data - Mythbusting COVID-19 Headlines

Smart & Biggar
Explore more from Smart & Biggar

Scientific advances provide hopeful front page news these days. Data, and in some cases a complete lack of data, affect how headlines are shaped in both life sciences and high technology.

CanadaCoronavirus (COVID-19)
Noel Courage
Noel Courage
Author LinkedIn connections

Scientific advances provide hopeful front page news these days. Data, and in some cases a complete lack of data, affect how headlines are shaped in both life sciences and high technology. Here are a few key recurring issues to keep in mind when reading the headlines about new technology developments in medicine and IT.

Getting Data – Faster, Farther Reach, High Quality

There is always evolving scientific debate, which is constructive and healthy. Good debate and data helps produce scientific consensus, which then allows society to move forward in tackling medical challenges. Pressing challenges in data gathering include getting quality data faster, and extending the reach of data collection.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Health Canada Updates Policies On Foreign Regulatory Actions, Summary Reporting, Compliance & Enforcement And Requests For New Data

Health Canada issued revised guidance on notifying Health Canada of foreign actions, effective October 1, 2026. The revised guidance clarifies the requirements to notify Health Canada of certain foreign regulatory actions specified in subsection C.01.050(2) of the Food and Drug Regulations in the specified foreign jurisdictions, which involve a serious risk of injury to human health and are relevant to the safety of the drug.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
Article

Health Canada Obtains Permanent Injunction To Prevent Illegal Sale Of Injectable Peptides By Canlab Research

Health Canada has secured a permanent injunction against Canlab Research, a Quebec-based online retailer, preventing the company from manufacturing, distributing, or selling unauthorized injectable peptides in Canada. This enforcement action follows years of regulatory warnings and provisional court orders aimed at stopping the illegal sale of peptide drugs promoted with unproven health claims for anti-aging, weight loss, and athletic performance.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
Article

A KTEP Ahead: Canada's New Mechanism For Advanced Examination Of Patent Applications

For a Canadian patent application to be examined, an applicant must file a request for examination with the Canadian Intellectual Property Office (CIPO). In most cases, the order in which applications are examined is based on the order that the requests for examination are received. An applicant may be able to accelerate examination of their patent application through several existing mechanisms, including advancing examination via special order, accelerating examination of applications related to green technology, and the Patent Prosecution Highway (PPH).
CanadaIntellectual Property
Smart & Biggar
Smart & Biggar